Trial Profile
Tolvaptan as A treatment for Refractory Cirrhotic Ascites in Japanese population (TARCAJa study)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Therapeutic Use
- Acronyms TARCAJa
- 11 Dec 2015 New trial record